hydroxychloroquine has been researched along with Acute Generalised Exanthematous Pustulosis in 30 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "severe distinctive cutaneous drug reaction, generalized pustular figurate erythema, closely linked with hydroxychloroquine (HCQ), has been documented." | 9.22 | Generalized Pustular Figurate Erythema in Patients with COVID-19 Treated with Hydroxychloroquine: A Systematic Review. ( Al Muqarrab, F; Almohssen, AA; Schwartz, RA, 2022) |
| "Hydroxychloroquine (HCQ)-induced acute generalized exanthematous pustulosis (AGEP) is poorly described in the literature." | 9.12 | Hydroxychloroquine-induced acute generalized exanthematous pustulosis: a series of seven patients and review of the literature. ( Amouri, M; Atheymen, R; Bahloul, E; Boudaya, S; Bougacha, N; Chaabouni, R; Charfi, S; Ennouri, M; Marrakchi, S; Sellami, K; Turki, H, 2021) |
| "A 28-year-old woman with rheumatoid arthritis, treated with leflunomide therapy without marked relief of joint pain, developed multiple rashes with pruritis covering the body 5 days after switching to hydroxychloroquine treatment." | 8.31 | Acute generalized exanthematous pustulosis caused by hydroxychloroquine in a patient with rheumatoid arthritis and CARD14 mutation: Case report. ( Chen, CM; Luo, F; Ma, WK; Xiong, H; Yao, XM; Yuan, XM, 2023) |
| " Four weeks prior, she had been initiated on hydroxychloroquine for a presumed diagnosis of cutaneous sarcoidosis." | 7.96 | Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report. ( Ackerman, L; Brahmbhatt, S; Coleman, I; Ruiz, G, 2020) |
| " HCQ is generally safe and may be prescribed to pregnant women." | 5.91 | Initiation of hydroxychloroquine therapy during pregnancy can cause adverse effects and alter pregnancy outcomes: A case of acute generalised exanthematous pustulosis induced by hydroxychloroquine in a patient with systemic lupus erythematosus. ( Kaneko, K; Murashima, A; Sago, H; Tanaka, R; Tsurane, K; Yoshida, K, 2023) |
| "severe distinctive cutaneous drug reaction, generalized pustular figurate erythema, closely linked with hydroxychloroquine (HCQ), has been documented." | 5.22 | Generalized Pustular Figurate Erythema in Patients with COVID-19 Treated with Hydroxychloroquine: A Systematic Review. ( Al Muqarrab, F; Almohssen, AA; Schwartz, RA, 2022) |
| "Hydroxychloroquine (HCQ)-induced acute generalized exanthematous pustulosis (AGEP) is poorly described in the literature." | 5.12 | Hydroxychloroquine-induced acute generalized exanthematous pustulosis: a series of seven patients and review of the literature. ( Amouri, M; Atheymen, R; Bahloul, E; Boudaya, S; Bougacha, N; Chaabouni, R; Charfi, S; Ennouri, M; Marrakchi, S; Sellami, K; Turki, H, 2021) |
| "A 28-year-old woman with rheumatoid arthritis, treated with leflunomide therapy without marked relief of joint pain, developed multiple rashes with pruritis covering the body 5 days after switching to hydroxychloroquine treatment." | 4.31 | Acute generalized exanthematous pustulosis caused by hydroxychloroquine in a patient with rheumatoid arthritis and CARD14 mutation: Case report. ( Chen, CM; Luo, F; Ma, WK; Xiong, H; Yao, XM; Yuan, XM, 2023) |
| " Four weeks prior, she had been initiated on hydroxychloroquine for a presumed diagnosis of cutaneous sarcoidosis." | 3.96 | Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report. ( Ackerman, L; Brahmbhatt, S; Coleman, I; Ruiz, G, 2020) |
| "Herein, acute generalized exanthematous pustulosis incited by hydroxychloroquine is briefly reviewed: a prolonged latency and recalcitrance to corticosteroids are noteworthy." | 2.58 | Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine. ( Castner, NB; Harris, JC; Motaparthi, K, 2018) |
| " HCQ is generally safe and may be prescribed to pregnant women." | 1.91 | Initiation of hydroxychloroquine therapy during pregnancy can cause adverse effects and alter pregnancy outcomes: A case of acute generalised exanthematous pustulosis induced by hydroxychloroquine in a patient with systemic lupus erythematosus. ( Kaneko, K; Murashima, A; Sago, H; Tanaka, R; Tsurane, K; Yoshida, K, 2023) |
| "Hydroxychloroquine is a medication that is used for the treatment of rheumatic and dermatologic conditions." | 1.62 | The necessity of patch testing in determining the causative drug of AGEP. ( Ghobadi Aski, S; Mofarrah, R; Nazemi, N; Nooshiravanpoor, P; Oshriehye, M, 2021) |
| "BACKGROUND Acute generalized exanthematous pustulosis (AGEP) is a rare exanthem characterized by the abrupt onset of numerous small, non-follicular, sterile pustules arising on an erythematous base." | 1.56 | Delayed Presentation of Acute Generalized Exanthematous Pustulosis Following Treatment with Cefepime in a Patient with COVID-19 without the Use of Hydroxychloroquine. ( Haraszti, S; Jensen, N; Sendil, S, 2020) |
| "Hydroxychloroquine (HCQ) is an antimalarial drug that is also used in some dermatologic and rheumatic diseases due to its immunosuppressive actions." | 1.51 | The First Pediatric Case of Acute Generalized Exanthematous Pustulosis Caused by Hydroxychloroquine. ( Barni, S; Giani, T; Liccioli, G; Marrani, E; Mori, F; Simonini, G, 2019) |
| "Hydroxychloroquine has a particularly long half-life and is a known cause of AGEP; therefore, it is possible that HCQ-induced AGEP may not follow the typical rapid recovery time." | 1.43 | Prolonged pustular eruption from hydroxychloroquine: an unusual case of acute generalized exanthematous pustulosis. ( Jolly, P; Morrell, DS; Pearson, KC; Runge, SR, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (20.00) | 24.3611 |
| 2020's | 24 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, G | 1 |
| Zhuo, N | 1 |
| Li, J | 1 |
| Demircioğlu, D | 1 |
| Karabıyık, N | 1 |
| Durmaz, EÖ | 1 |
| Demirkesen, C | 1 |
| Şahin, S | 1 |
| Odorici, G | 1 |
| Schenetti, C | 1 |
| Pacetti, L | 1 |
| Schettini, N | 1 |
| Gaban, A | 1 |
| Mantovani, L | 1 |
| Yan, C | 1 |
| Shang, Q | 1 |
| Geng, S | 1 |
| Tsurane, K | 3 |
| Kaneko, K | 3 |
| Yoshida, K | 3 |
| Tanaka, R | 3 |
| Sago, H | 3 |
| Murashima, A | 3 |
| Novruzov, E | 2 |
| Schmitt, D | 2 |
| Mori, Y | 2 |
| Kirchner, J | 2 |
| Kobbe, G | 2 |
| Reifenberger, J | 2 |
| Mamlins, E | 2 |
| Antke, C | 2 |
| Giesel, FL | 2 |
| Al Muqarrab, F | 1 |
| Schwartz, RA | 2 |
| Almohssen, AA | 1 |
| Luo, F | 1 |
| Yuan, XM | 1 |
| Xiong, H | 1 |
| Chen, CM | 1 |
| Ma, WK | 1 |
| Yao, XM | 1 |
| Matsuda-Hirose, H | 1 |
| Sho, Y | 1 |
| Yamate, T | 1 |
| Nakamura, Y | 1 |
| Saito, K | 1 |
| Takeo, N | 1 |
| Nishida, H | 1 |
| Ishii, K | 1 |
| Sugiura, K | 1 |
| Hatano, Y | 1 |
| Janniger, CK | 1 |
| Robustelli Test, E | 1 |
| Vezzoli, P | 1 |
| Carugno, A | 1 |
| Raponi, F | 1 |
| Gianatti, A | 1 |
| Rongioletti, F | 1 |
| Sena, P | 1 |
| Litaiem, N | 1 |
| Hajlaoui, K | 1 |
| Karray, M | 1 |
| Slouma, M | 1 |
| Zeglaoui, F | 1 |
| Delaleu, J | 1 |
| Deniau, B | 1 |
| Battistella, M | 1 |
| de Masson, A | 1 |
| Bensaid, B | 1 |
| Jachiet, M | 1 |
| Lazaridou, I | 1 |
| Bagot, M | 1 |
| Bouaziz, JD | 1 |
| Enos, T | 1 |
| Jeong, HS | 1 |
| Vandergriff, T | 1 |
| Jacobe, HT | 1 |
| Chong, BF | 1 |
| Kuraitis, D | 1 |
| Murina, A | 1 |
| Otake-Irie, H | 1 |
| Nakajima, S | 1 |
| Okamoto, N | 1 |
| Toichi, E | 1 |
| Nomura, T | 1 |
| Kabashima, K | 1 |
| Nili, A | 1 |
| Zarei, E | 1 |
| Ghamari, A | 1 |
| Farid, AS | 1 |
| Tavakolpour, S | 1 |
| Daneshpazhooh, M | 1 |
| Mahmoudi, H | 1 |
| Haraszti, S | 1 |
| Sendil, S | 1 |
| Jensen, N | 1 |
| Coleman, I | 1 |
| Ruiz, G | 1 |
| Brahmbhatt, S | 1 |
| Ackerman, L | 1 |
| Mofarrah, R | 2 |
| Oshriehye, M | 1 |
| Ghobadi Aski, S | 1 |
| Nazemi, N | 1 |
| Nooshiravanpoor, P | 1 |
| Chaabouni, R | 1 |
| Bahloul, E | 1 |
| Ennouri, M | 1 |
| Atheymen, R | 1 |
| Sellami, K | 1 |
| Marrakchi, S | 1 |
| Charfi, S | 1 |
| Boudaya, S | 1 |
| Amouri, M | 1 |
| Bougacha, N | 1 |
| Turki, H | 1 |
| Kantor, J | 1 |
| Atak, MF | 1 |
| Farabi, B | 1 |
| Akbayrak, A | 1 |
| Kalelioğlu, MB | 1 |
| Rao, BK | 1 |
| Hsieh, CH | 1 |
| Yao, CA | 1 |
| Lo, Y | 1 |
| Castner, NB | 1 |
| Harris, JC | 1 |
| Motaparthi, K | 1 |
| Liccioli, G | 1 |
| Marrani, E | 1 |
| Giani, T | 1 |
| Simonini, G | 1 |
| Barni, S | 1 |
| Mori, F | 1 |
| Pastushenko, I | 1 |
| Gracia-Cazaña, T | 1 |
| Morales-Moya, AL | 1 |
| Grasa, MP | 1 |
| Zhang, Z | 1 |
| Liu, X | 1 |
| Pearson, KC | 1 |
| Morrell, DS | 1 |
| Runge, SR | 1 |
| Jolly, P | 1 |
| Djennane, M | 1 |
| Tablit, I | 1 |
| Billhot, M | 1 |
| Banal, F | 1 |
4 reviews available for hydroxychloroquine and Acute Generalised Exanthematous Pustulosis
| Article | Year |
|---|---|
Generalized Pustular Figurate Erythema in Patients with COVID-19 Treated with Hydroxychloroquine: A Systematic Review.
Topics: Acute Generalized Exanthematous Pustulosis; COVID-19; COVID-19 Drug Treatment; Erythema; Humans; Hyd | 2022 |
Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine.
Topics: Acute Generalized Exanthematous Pustulosis; Adrenal Cortex Hormones; Coronavirus Infections; COVID-1 | 2020 |
Hydroxychloroquine-induced acute generalized exanthematous pustulosis: a series of seven patients and review of the literature.
Topics: Acute Generalized Exanthematous Pustulosis; Exanthema; Female; Humans; Hydroxychloroquine; Interleuk | 2021 |
Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine.
Topics: Acute Generalized Exanthematous Pustulosis; Cyclosporine; Dermatologic Agents; Female; Glucocorticoi | 2018 |
26 other studies available for hydroxychloroquine and Acute Generalised Exanthematous Pustulosis
| Article | Year |
|---|---|
Acute generalized exanthematous pustulosis induced by generic hydroxychloroquine.
Topics: Acute Generalized Exanthematous Pustulosis; Humans; Hydroxychloroquine | 2022 |
AGEP sine pustulosis induced by hydroxychloroquine used for COVID-19 infection.
Topics: Acute Generalized Exanthematous Pustulosis; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; SAR | 2022 |
Acute generalized exanthematous pustulosis due to hydroxichloroquine.
Topics: Acute Generalized Exanthematous Pustulosis; Humans; Hydroxychloroquine | 2022 |
Hydroxychloroquine-induced acute generalized exanthematous pustulosis in an orofacial granulomatosis patient with homozygous IL36RN mutation.
Topics: Acute Generalized Exanthematous Pustulosis; Granulomatosis, Orofacial; Homozygote; Humans; Hydroxych | 2022 |
Initiation of hydroxychloroquine therapy during pregnancy can cause adverse effects and alter pregnancy outcomes: A case of acute generalised exanthematous pustulosis induced by hydroxychloroquine in a patient with systemic lupus erythematosus.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Antirheumatic Agents; Cesarean Section; Child; Di | 2023 |
Initiation of hydroxychloroquine therapy during pregnancy can cause adverse effects and alter pregnancy outcomes: A case of acute generalised exanthematous pustulosis induced by hydroxychloroquine in a patient with systemic lupus erythematosus.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Antirheumatic Agents; Cesarean Section; Child; Di | 2023 |
Initiation of hydroxychloroquine therapy during pregnancy can cause adverse effects and alter pregnancy outcomes: A case of acute generalised exanthematous pustulosis induced by hydroxychloroquine in a patient with systemic lupus erythematosus.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Antirheumatic Agents; Cesarean Section; Child; Di | 2023 |
Initiation of hydroxychloroquine therapy during pregnancy can cause adverse effects and alter pregnancy outcomes: A case of acute generalised exanthematous pustulosis induced by hydroxychloroquine in a patient with systemic lupus erythematosus.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Antirheumatic Agents; Cesarean Section; Child; Di | 2023 |
Initiation of hydroxychloroquine therapy during pregnancy can cause adverse effects and alter pregnancy outcomes: A case of acute generalised exanthematous pustulosis induced by hydroxychloroquine in a patient with systemic lupus erythematosus.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Antirheumatic Agents; Cesarean Section; Child; Di | 2023 |
Initiation of hydroxychloroquine therapy during pregnancy can cause adverse effects and alter pregnancy outcomes: A case of acute generalised exanthematous pustulosis induced by hydroxychloroquine in a patient with systemic lupus erythematosus.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Antirheumatic Agents; Cesarean Section; Child; Di | 2023 |
Initiation of hydroxychloroquine therapy during pregnancy can cause adverse effects and alter pregnancy outcomes: A case of acute generalised exanthematous pustulosis induced by hydroxychloroquine in a patient with systemic lupus erythematosus.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Antirheumatic Agents; Cesarean Section; Child; Di | 2023 |
Initiation of hydroxychloroquine therapy during pregnancy can cause adverse effects and alter pregnancy outcomes: A case of acute generalised exanthematous pustulosis induced by hydroxychloroquine in a patient with systemic lupus erythematosus.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Antirheumatic Agents; Cesarean Section; Child; Di | 2023 |
Initiation of hydroxychloroquine therapy during pregnancy can cause adverse effects and alter pregnancy outcomes: A case of acute generalised exanthematous pustulosis induced by hydroxychloroquine in a patient with systemic lupus erythematosus.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Antirheumatic Agents; Cesarean Section; Child; Di | 2023 |
Unique [
Topics: Acute Generalized Exanthematous Pustulosis; Fluorodeoxyglucose F18; Humans; Hydroxychloroquine | 2023 |
Unique [
Topics: Acute Generalized Exanthematous Pustulosis; Fluorodeoxyglucose F18; Humans; Hydroxychloroquine | 2023 |
Unique [
Topics: Acute Generalized Exanthematous Pustulosis; Fluorodeoxyglucose F18; Humans; Hydroxychloroquine | 2023 |
Unique [
Topics: Acute Generalized Exanthematous Pustulosis; Fluorodeoxyglucose F18; Humans; Hydroxychloroquine | 2023 |
Acute generalized exanthematous pustulosis caused by hydroxychloroquine in a patient with rheumatoid arthritis and CARD14 mutation: Case report.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Arthritis, Rheumatoid; CARD Signaling Adaptor Pro | 2023 |
Acute generalized exanthematous pustulosis induced by hydroxychloroquine successfully treated with etretinate.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Antirheumatic Agents; Biopsy; Etretinate; Female; | 2020 |
Acute generalized exanthematous pustulosis with erythema multiforme-like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID-19).
Topics: Acute Generalized Exanthematous Pustulosis; Aged; COVID-19; COVID-19 Drug Treatment; Female; Humans; | 2020 |
Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.
Topics: Acute Generalized Exanthematous Pustulosis; Betacoronavirus; Chemoprevention; Coronavirus Infections | 2020 |
Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19.
Topics: Acute Generalized Exanthematous Pustulosis; Aged; Antirheumatic Agents; Betacoronavirus; Coronavirus | 2020 |
Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Antiviral Agents; COVID-19; COVID-19 Drug Treatme | 2020 |
Facts, not Fear: Safety of Hydroxychloroquine.
Topics: Acute Generalized Exanthematous Pustulosis; Agranulocytosis; Anemia, Aplastic; Antirheumatic Agents; | 2020 |
Prolonged acute generalized exanthematous pustulosis and atypical target-like lesions induced by hydroxychloroquine.
Topics: Acute Generalized Exanthematous Pustulosis; Antirheumatic Agents; Humans; Hydroxychloroquine | 2020 |
Acute generalized exanthematous pustulosis with a focus on hydroxychloroquine: A 10-year experience in a skin hospital.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Aged; Female; Humans; Hydroxychloroquine; Male; M | 2020 |
Delayed Presentation of Acute Generalized Exanthematous Pustulosis Following Treatment with Cefepime in a Patient with COVID-19 without the Use of Hydroxychloroquine.
Topics: Acute Generalized Exanthematous Pustulosis; Aged; Betacoronavirus; Biopsy; Coronavirus Infections; C | 2020 |
Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
Topics: Acute Generalized Exanthematous Pustulosis; Aged; Antimalarials; Biopsy; Coronavirus Infections; COV | 2020 |
The necessity of patch testing in determining the causative drug of AGEP.
Topics: Acute Generalized Exanthematous Pustulosis; Female; Humans; Hydroxychloroquine; Middle Aged; Patch T | 2021 |
June 2021: Acute generalized exanthematous pustulosis in Asia.
Topics: Acute Generalized Exanthematous Pustulosis; Asia; Humans; Hydroxychloroquine | 2021 |
Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID-19 without hydroxychloroquine use: Report of the first case.
Topics: Acute Generalized Exanthematous Pustulosis; Amides; COVID-19 Drug Treatment; Humans; Hydroxychloroqu | 2021 |
Acute generalized exanthematous pustulosis induced by hydroxychloroquine.
Topics: Acute Generalized Exanthematous Pustulosis; Female; Humans; Hydroxychloroquine; Middle Aged | 2021 |
The First Pediatric Case of Acute Generalized Exanthematous Pustulosis Caused by Hydroxychloroquine.
Topics: Acute Generalized Exanthematous Pustulosis; Antirheumatic Agents; Child; Female; Histamine Antagonis | 2019 |
[Acute cutaneous pustular eruption due to hydroxychloroquine].
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Antirheumatic Agents; Female; Humans; Hydroxychlo | 2014 |
Images in clinical medicine. Acute generalized exanthematous pustulosis.
Topics: Acute Generalized Exanthematous Pustulosis; Female; Humans; Hydroxychloroquine; Middle Aged; Sjogren | 2015 |
Prolonged pustular eruption from hydroxychloroquine: an unusual case of acute generalized exanthematous pustulosis.
Topics: Acute Generalized Exanthematous Pustulosis; Antirheumatic Agents; Female; Half-Life; Humans; Hydroxy | 2016 |
[Acute generalized exanthematic pustulosis induced by hydroxychloroquine: case report].
Topics: Acute Generalized Exanthematous Pustulosis; Antirheumatic Agents; Diagnosis, Differential; Female; H | 2010 |